BRIEF published on 09/10/2026 at 20:35, 1 day 16 hours ago Gaumont's half-year results as of June 30, 2026 Financial Results Revenue Film Production Gaumont Public Delisting Offer
BRIEF published on 09/10/2026 at 20:35, 1 day 16 hours ago Résultats semestriels de Gaumont au 30 juin 2026 Chiffre D'affaires Résultats Financiers Offre Publique De Retrait Gaumont Production Cinématographique
PRESS RELEASE published on 09/10/2026 at 20:30, 1 day 17 hours ago GAUMONT : Résultats semestriels consolidés au 30 juin 2026 Le Conseil d’administration de Gaumont annonce ses résultats semestriels au 30 juin 2026: Chiffre d’affaires consolidé en hausse de 33%, résultat net amélioré. Détails des activités cinématographiques et audiovisuelles Chiffre D'affaires Résultats Semestriels Cinéma Audiovisuel Gaumont
BRIEF published on 06/05/2026 at 20:05, 3 months 6 days ago GAUMONT: Number of Voting Rights as of May 31, 2026 Euronext Paris Share Capital Shares Right To Vote Gaumont
BRIEF published on 06/05/2026 at 20:05, 3 months 6 days ago GAUMONT : Nombre de Droits de Vote au 31 Mai 2026 Euronext Paris Capital Social Actions Droit De Vote Gaumont
PRESS RELEASE published on 06/05/2026 at 20:00, 3 months 6 days ago GAUMONT - Informations relatives au nombre total de droits de vote et d'actions du capital social au 31 mai 2026 Gaumont communique le total des droits de vote et d'actions, conformément aux articles du code de commerce et du règlement de l'AMF Euronext Paris Droits De Vote Actions AMF Gaumont
BRIEF published on 05/15/2026 at 20:05, 3 months 27 days ago État des droits de vote et actions de Gaumont au 30 avril 2026 Droits De Vote Euronext Actions Finance Gaumont
BRIEF published on 05/15/2026 at 20:05, 3 months 27 days ago Status of voting rights and shares of Gaumont as of April 30, 2026 Voting Rights Shares Euronext Finance Gaumont
PRESS RELEASE published on 05/15/2026 at 20:00, 3 months 27 days ago GAUMONT : Informations relatives au nombre total de droits de vote et d'actions du capital social au 30 avril 2026 Gaumont communique les informations relatives aux droits de vote et d'actions au 30/04/2026 conformément à la réglementation financière en vigueur Autorité Des Marchés Financiers Euronext Paris Droits De Vote Capital Social Gaumont
BRIEF published on 04/08/2026 at 20:05, 5 months 3 days ago Gaumont : Disposition des documents pour l'Assemblée générale 2026 Euronext Paris Actionnaires Assemblée Générale Documents Préparatoires Gaumont
Published on 09/12/2026 at 02:35, 10 hours 55 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 30 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 25 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 5 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 30 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 15 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 20 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 45 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 15 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
